For many year’s I have watched this company grow and I, quite literally, jumped for joy after hearing the news that they had been granted FDA clearance.
The concept behind the pioneering Paxman Scalp Cooling System came when the mother of four, Sue Paxman, experienced first-hand the trauma of chemotherapy induced hair loss.
The Company has since been on a personal journey to ensure Sue’s legacy lives on by helping women around the globe minimise chemotherapy-induced hair loss and contribute to their quality of life.
“Hair loss is consistently ranked in the top five most distressing cancer chemotherapy side effects,” explains Richard Paxman, CEO at Paxman.
“Like my mum, many people find hair loss to be extremely traumatic. It is estimated that 8% of patients actually refuse chemotherapy because they do not want to lose their hair. After experiencing this first hand, we have been determined to change this, and help minimise hair loss in women who are undergoing chemotherapy for breast cancer, positively contributing to their overall health and recovery.
Over the next 12 months, Paxman plans to install 250 systems across the U.S. and will be working with a large number of cancer centres and large community oncology groups to roll out their scalp cooling systems.
Paxman aims to revolutionise the current landscape of scalp cooling by ensuring that affordability is at the centre of the treatment giving more patient choice.
To read more visit http://www.ajmc.com/newsroom/paxman-scalp-cooling-system-is-fda-approved-for-chemotherapy-associated-alopecia